Inovio Clinical Trials: Infectious Disease

Inovio Pharmaceuticals or its partners/collaborators are conducting the following ongoing clinical trials for the treatment of infectious diseases. Patients are being recruited for these trials, with details available by following the links below.

Indications: Hepatitis C virus (Partner/Sponsor: ChronTech)

Treatment: Chronvac-C®

Study title: Chronvac-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects

Trial Stage: Phase II

http://www.clinicaltrials.gov/ct2/show/NCT01335711?term=hepatitis+c+chrontech&rank=1

Indications: HIV

Treatment: PENNVAX™-B HIV Preventative Vaccine (HVTN-080)

Study title: A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of PENNVAX™-B (Gag, Pol, Env) Vaccine, With or Without IL-12 DNA Plasmid, Delivered Via Electroporation in Healthy, HIV-1-Uninfected Adult Participants

Trial Stage: Phase I

http://www.clinicaltrials.gov/ct2/show/NCT00991354?term=PENNVAX+electroporation&rank=1

Indications: HIV

Treatment: PENNVAX™-B HIV Therapeutic Vaccine

Study title: A Phase I, Open Label Study to Evaluate the Safety, Tolerability, and Immunogenicity of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants

Trial Stage: Phase I

http://www.clinicaltrials.gov/ct2/show/NCT01082692?term=hiv+electroporation&rank=1

Indications: HIV

Treatment: PENNVAX™-G HIV Preventive Vaccine

Study title: A Study of the Safety and Immunogenicity of PENNVAX™-G DNA (ENV & GAG) Administered by Intramuscular Biojector 2000 or CELLECTRA® Intramuscular Electroporation Device Followed by MVA-CMDR (HIV-1 CM235 ENV/CM240 GAG/POL) Boost in Healthy, HIV Uninfected Adults

Trial Stage: Phase I

http://www.clinicaltrials.gov/ct2/show/NCT01260727?term=mhrp+hiv&rank=1

Indications: Avian Influenza

Treatment: VGX-3400X

Study title: Study of VGX3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults

Trial Stage: Phase I (study is ongoing, but not recruiting participants)

http://www.clinicaltrials.gov/ct2/show/NCT01142362?term=influenza+inovio&rank=1

Indications: Universal Influenza

Treatment: INO-3510

Study title: Phase I, Open Label Study to Evaluate Safety, Tolerability and Immunogenicity of Multiple Combinations of H1 and H5 Influenza Hemagglutinin Plasmids Administered ID Followed by in Vivo Electroporation With CELLECTRA®-3P in Healthy Adults

Trial Stage: Phase I

http://www.clinicaltrials.gov/ct2/show/NCT01405885?term=NCT01405885&rank=1